U.S. Pharmaceuticals & Biotech Breakout Stocks

Nuvalent

Market Cap: US$7.0b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

Tango Therapeutics

Market Cap: US$4.5b

A precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need.

Oruka Therapeutics

Market Cap: US$3.9b

A clinical-stage biopharmaceutical company, focuses on developing novel monoclonal antibody therapeutics for psoriasis (PsO), and other inflammatory and immunology (I&I) indications.

Zevra Therapeutics

Market Cap: US$714.7m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

ACC Aviation Holdings

Market Cap: US$464.0m

Engages in the development of cannabis powder products.

Elicio Therapeutics

Market Cap: US$249.3m

A clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer.

EOM Pharmaceuticals Holdings

Market Cap: US$26.9m

A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.

National Graphite

Market Cap: US$6.8m

Does not have significant operations.

Enzolytics

Market Cap: US$5.8m

A drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases.

Mosaic ImmunoEngineering

Market Cap: US$4.9m

A development-stage biotechnology company, focuses on advancing and commercialization of immunotherapies for the treatment of cancer.

Eloxx Pharmaceuticals

Market Cap: US$4.3m

A clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia.

Vaccinex

Market Cap: US$2.7m

A clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat cancer, neurodegenerative diseases, and autoimmune disorders.

Premier Biomedical

Market Cap: US$1.8m

A research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases.

Dakshidin Corporation

Market Cap: US$1.8m

Through its subsidiaries, operates as a CBD/cannabis-based medical product company.

Allstar Health Brands

Market Cap: US$210.1k

A specialty health care products company, focuses on enhancing health and quality of life by offering select medicines, natural nutritional supplements, and over the counter remedies in the Americas.

Hero Technologies

Market Cap: US$56.4k

Operates as an early-stage cannabis company.

Vaxxinity

Market Cap: US$25.3k

A biotechnology company, focuses on developing product candidates for human use in the fields of neurology, cardiovascular diseases, and coronaviruses in the United States.

Navidea Biopharmaceuticals

Market Cap: US$10.0k

A biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics.

AmeriCann

Market Cap: US$2.4k

Designs, develops, leases, and operates cannabis cultivation, processing, and manufacturing facilities in the United States.

Juva Life

Market Cap: US$164.0

Acquires, owns, and operates in cannabis business in medical and recreational cannabis sectors in California, the United States.